Scientist profiles A-F

Please note Dr. Daneman is not accepting summer students at this time.

Administrative Assistant: Karen Arbour
Phone: 416-480-4055, ext. 3780
Email: karen.arbour@ices.on.ca

Education:

• B.A.Sc., 1997, McMaster University, Canada
• MD, 2001, University of Toronto, Canada
• FRCPC, 2005, internal medicine, U of T, Canada
• FRCPC, 2006, infectious diseases, U of T, Canada
• M.Sc., 2008, clinical epidemiology, U of T, Canada

Appointments and Affiliations:

• Scientist, Evaluative Clinical Sciences, Trauma, Emergency & Critical Care Research Program, Sunnybrook Research Institute
• Assistant professor, faculty of medicine, U of T

Research Foci:

• Antibiotic stewardship and resistance
• Hospital-acquired infections
• Clostridium difficile
• Infections of critical care
• Bacteremia

Research Summary:

Dr. Daneman is funded by a clinician-scientist salary award from the Canadian Institutes of Health Research. His research program uses hospital- and provincial-level data to optimize prediction, prevention and treatment of hospital-acquired infections, with specific themes including: antibiotic stewardship and resistance, Clostridium difficile, infections of critical care and bacteremia.

Selected Publications:

See current publications list at PubMed.

1. Daneman N, Campitelli MA, Giannakeas V, Morris AM, Bell CM, Maxwell CJ, Jeffs L, Austin PC, Bronskill SE. Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities. CMAJ. 2017 Jun 26;189(25):E851–E860.
2. Daneman N, Rishu AH, Xiong W, Bagshaw SM, Dodek P, Hall R, et al. Antibiotic treatment durations among Canadian critically ill patients with bacteremia. Crit Care Med. Epub 2015 Oct 22. doi: 10.1097/CCM.0000000000001393.
3. Daneman N, Guttmann A, Wang X, Ma X, Gibson D, Stukel TA. The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study. BMJ Qual Saf. 2015 Jul;24(7):435–43.
4. Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med. 2015 Apr;175(4):626–33.
5. Daneman N, Bronskill SE, Gruneir A, Newman AM, Fischer HD, Rochon PA, Anderson GM, Bell CM. Variability in antibiotic use across nursing homes and the risk of antibiotic-related adverse outcomes for individual residents. JAMA Intern Med. 2015 Aug;175(8):1331–9.
6. Daneman N, Rishu AH, Xiong W, Bagshaw SM, Cook DJ, Dodek P, et al. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial. Trials. 2015 Apr 18;16(1):173.

Related News and Stories

• A fine balance (SRI Magazine, 2017)
• SRI scientists top the national average in successful CIHR project grants: Over a dozen projects approved (June 2, 2017)
• CIHR responds to revolt while releasing results: Peer rebellion brings promise of change to granting agency (July 18, 2016)
• National agency recognizes scientific excellence at Sunnybrook Research Institute: Scientists score high with multimillion-dollar funding investment (Oct. 13, 2015)
• Panning for patterns: Using hospital data to map and fight antimicrobial resistance (July 21, 2015)
• Heavy use of antibiotics in nursing homes may raise risk for all residents (CBC, June 29, 2015)
• Ask a scientist: What is the hardest part about your research to communicate to someone without a scientific background? (SRI Magazine, 2013)
• Hospital C. difficile rates decline with mandatory reporting (CBC, July 17, 2012)
• Wonder drugs no more: SRI scientists lead the crusade against 21-century superbugs (SRI Magazine, 2010)